Long Term Nutritional Supplementation Reduces Progression Of Age Related Macular Degeneration

Long-term nutritional supplementation reduces progression of age-related macular degeneration

Long-term nutritional supplementation reduces progression of age-related macular degeneration

Tuesday, April 23, 2013. An article published online on April 10, 2013 in the journal Ophthalmology reports long-term benefit from supplementing with a nutritional formula containing antioxidants and zinc in men and women with age-related macular degeneration. Age-related macular degeneration (AMD) is characterized by the deterioration of the eye's macula, which results in impairment of central vision. Although there is currently no cure, a combination of beta-carotene, vitamins C and E, and zinc were associated with a reduction in the progression of the disease in a trial that concluded in 2001.

For the current investigation, Emily Y. Chew MD of the National Eye Institute and her associates evaluated data from 3,549 follow-up participants in the Age-Related Eye Disease Study (AREDS), which enrolled 4,757 men and women from 1992 through 1998. Subjects were placed into one of four AMD categories according to the extent of drusen in each eye, the presence of advanced disease, and visual acuity. Participants were divided to receive a placebo, antioxidant vitamins (beta-carotene, vitamin C and vitamin E), zinc plus copper, or antioxidants plus zinc and copper until the trial's completion in 2001. The subjects were invited to participate in a follow-up study, during which annual eye examinations were conducted until November, 2005.

Among participants whose macular degeneration was classified as category 2 (early), 3 (intermediate) and 4 (advanced or neovascular disease in one eye, or central geographic atrophy), those who received antioxidants plus zinc in the clinical trial continued to experience a significant reduction in the risk of developing advanced macular degeneration or neovascular age-related macular degeneration (characterized by abnormal blood vessel growth into the retina) by the end of the follow-up study, in comparison with the placebo group. Supplementation with antioxidants alone was also associated with a reduction in the disease's progression. A separate analysis limited the significance of the finding to subjects in category 4, for whom disease progression was evaluated in the eye that did not have advanced disease at the beginning of the study. Subjects in this category who received antioxidants plus zinc in the clinical trial had a 56 percent lower risk of developing advanced macular degeneration in comparison with those in the placebo group. They additionally experienced a reduction in moderate and severe vision loss.

When mortality was analyzed, those who received zinc were found to have a 17 percent lower adjusted risk of dying from any cause over a median follow-up period of 10.5 years in comparison with those who did not receive the mineral. The protective effect was strongest against death from circulatory diseases.

"Participants in the AREDS clinical trial who had been assigned to the antioxidant and zinc formulation continued to show a reduced odds of developing advanced AMD, especially neovascular AMD, 5 years after the clinical trial ended," the authors conclude. "We continue to recommend the use of the AREDS formulation in persons with intermediate AMD or advanced AMD in 1 eye and persons at moderate to high risk of developing advanced AMD."

What's Hot Highlight

Omega-3 fatty acid metabolite inhibits angiogenesis

What's Hot

In an article published online on April 3, 2013 in the Proceedings of the National Academy of Sciences, researchers from the University of California, Davis report an antiangiogenic effect for a metabolite of the omega-3 fatty acid docosahexaenoic acid (DHA). Angiogenesis occurs when tumors grow new blood vessels, enabling them to grow and spread. The process also occurs during neovascular age-related macular degeneration, in which abnormal blood vessel growth develops within the eye.

Bruce D. Hammock of UC Davis' Department of Entomology and his associates found that epoxydocosopentaenoic acids (EDPs) metabolized from DHA reduce tumor angiogenesis in mice, and that metabolites of the omega-6 acid arachidonic acid known as epoxyeicosatrienoic acids (EETs) slightly increase it. Further research revealed that EDPs additionally suppress endothelial cell migration needed new blood vessel formation.

"Our investigation opens up a new understanding of the pathways by which omega-3 fatty acids exert their biologic effects," noted lead author Guodong Zhang, who is a postdoctoral researcher in Dr Hammock's laboratory. "As far as we know, EDPs are the first signaling lipids that have been discovered to have such potent anticancer effects. Researchers may be able to use EDPs as structural targets to develop stable analogs as anticancer agents."

"Our results designate EDPs and EETs as unique mediators of an angiogenic switch to regulate tumorigenesis," noted study coauthor Katherine W. Ferrara, who is a professor in the UC Davis Department of Biomedical Engineering. "They also implicate a novel mechanistic linkage between omega-3 and omega-6 fatty acids and cancers."

Life Extension on YouTube!


Life Extension on YouTube! 


Watch Life Extension's Michael A. Smith, MD explain the benefits of Life Extension membership, blood tests, nutritional supplements and more on You Tube.

A graduate of the University of Texas Southwestern Medical School in Dallas, TX, Dr. Mike is the online personality for Life Extension®. An author, blogger, lecturer and national media personality, he has created and conducted numerous health related webinars as well as scripted and hosted a variety of informative online videos.

Titles include "Treating Alzheimer's in the 21st century," "Can Your Body's Immune System Cure Cancer?" "How to Prime Your Brain for Better Memory," and many more!

Latest Supplements 

Rich Rewards™ Black Bean Vegetable Soup
Item #01712


Extensive documentation demonstrates that black beans:

  • Significantly support blood sugar levels that are already within the normal range even over a prolonged period—and even when combined with higher-glycemic foods.
  • Provide significant support for the DNA integrity of bone marrow and peripheral blood cells.
  • Are associated with support for cardiovascular health.
  • Improve short-term satiety and weight loss, when combined with a reduced calorie diet.
  • Promote healthy gastrointestinal function, providing healthy colonic bacteria with the perfect mixture of compounds to promote the production of butyric acid, which is used by colon-lining cells to keep the lower digestive tract functioning smoothly.


Kyolic® Garlic Formula 102

Skin Restoring Phytoceramides with Lipowheat®
Item #01596

add to cart

Phytoceramides have been available to Japanese women as a functional food since 2000. The hydrating action of Lipowheat® phytoceramides has proven so effective in clinical trials, they're now approved as a dietary ingredient by the FDA. For example, after three months of ingesting 200 mg a day of Lipowheat®, a group of people reported dramatic improvement in the look and feel of their skin. These results were verified by electrochemical analysis showing that 95% of participants exhibited improved skin hydration. Better yet, all subjects who experienced itching at the onset of the study reported sharply decreased itching or complete elimination of the problem by the end of the study.



Life Extension Update What's Hot
Greater omega-3 fatty acid intake associated with protection against advanced age-related macular degeneration Greater intake of several nutrients combined with low glycemic foods linked to reduced risk of macular degeneration
Latest macular degeneration study plans to add new nutritional supplements AMA journal says vitamin E preventive benefit in macular degeneration outweighs possible risks
Elevated homocysteine linked with macular degeneration risk C-reactive protein levels linked with macular degeneration
Life Extension Magazine® Health Topics
Preventing macular degeneration: a new theory Age-related macular degeneration
The role of nutrition in macular degeneration Eye health
Macular degeneration epidemic: how aging people can preserve their eyesight